• VEGFC–Macrophage Axis in NASH: Evidence from Inhibition Stud

  2026-06-18

  This study demonstrates that targeting VEGFC signaling in hepatocytes disrupts macrophage-driven fibrosis in a mouse model of NASH. Both naringin and selective VEGFR-3 inhibition (SAR131675) ameliorate hepatic inflammation and fibrotic progression, highlighting VEGFC–macrophage crosstalk as a promising research target.

• Applied Workflows with SB 431542: ALK5 Inhibitor in TGF-β Re

  2026-06-18

  SB 431542 stands as a benchmark ALK5 inhibitor for dissecting the TGF-β pathway, enabling precise modulation of Smad2/3 signaling in cancer, fibrosis, and immunology models. This article delivers actionable protocols, troubleshooting strategies, and research-driven insights, translating the latest mechanistic findings into practical bench applications.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-17

  A recent study reveals that naturally occurring angiotensin fragments, including Angiotensin 1/2 (1-6), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings establish a mechanistic bridge between renin-angiotensin system peptides and viral entry, with implications for both cardiovascular and infectious disease research.

• Luminescent ATP Detection Assay Kit: Precision in Glioblasto

  2026-06-17

  The Luminescent ATP Detection Assay Kit leverages firefly luciferase for ultrasensitive ATP quantification, streamlining metabolic research in cells and tissues. Its robust linearity and sample compatibility empower energy metabolism studies, including those dissecting glycolytic drivers in glioblastoma.

• EGCG Nanoparticles Enhance FLASH-RT Antitumor Efficacy via D

  2026-06-16

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate radiotherapy (FLASH-RT) by amplifying DNA damage and orchestrating a favorable immune response. The findings suggest new avenues for improving cancer radiotherapy efficacy and immune modulation.

• Machine Learning Accelerates Discovery of Novel Senolytics

  2026-06-16

  This paper introduces a data-driven approach leveraging machine learning to identify new senolytic compounds, substantially reducing the cost and scale of traditional drug screening. The findings provide actionable insights for researchers targeting cellular senescence in cancer and aging.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow

  2026-06-15

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody provides robust detection and signal amplification for rabbit primary antibodies in immunoassays such as ELISA, Western blot, IHC, and IC. This reagent is not intended for diagnostic or clinical applications and should be avoided in workflows requiring monoclonal or subclass-specific detection.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in Vascular

  2026-06-15

  Angiotensin II (SKU A1042) is an essential tool for modeling hypertension mechanisms, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy in cellular and animal research. It provides defined, reproducible activation of angiotensin receptors and downstream signaling. Researchers should avoid extrapolating its use to diagnostic or clinical applications and adhere closely to recommended protocols for optimal results.

• Imatinib Hydrochloride: Optimized Protocols for Cancer Resea

  2026-06-14

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor, enabling precise inhibition of v-Abl, c-Kit, and PDGFR signaling in advanced cancer models. Explore optimized workflows, troubleshooting guidance, and the latest mechanistic insights that empower robust chronic myelogenous leukemia and gastrointestinal stromal tumor research using APExBIO’s high-quality compound.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Reliable ΔΨ

  2026-06-13

  This article guides biomedical researchers through common laboratory scenarios in mitochondrial function analysis and cell apoptosis detection, highlighting how the JC-1 Mitochondrial Membrane Potential Assay Kit (SKU K2002) delivers reproducible, quantitative results. Grounded in validated protocols and supported by recent literature, it offers actionable insights for choosing robust ΔΨm assays and optimizing experimental workflows.

• DiR (DiIC 18 (7)) in Long-Term Membrane Imaging: Innovative

  2026-06-12

  Discover how DiR (DiIC 18 (7)) enables advanced, long-term cell membrane imaging and tracking with minimal cytotoxicity. This article explores breakthrough applications, practical assay guidance, and the latest reference-backed innovations for researchers seeking precision membrane labeling.

• Sulforaphane Mitigates PM2.5-Induced COPD via Nrf2 and EGFR

  2026-06-12

  This study demonstrates that sulforaphane (SFN) attenuates lung injury and oxidative stress in PM2.5-induced COPD by activating Nrf2 signaling and suppressing EGFR/PI3K/AKT pathways. The research integrates in vivo, in vitro, and network pharmacology analyses, offering mechanistic insights and supporting translational strategies for oxidative stress intervention.

• Afatinib (BIBW 2992): Precision EGFR Pathway Inhibition in A

  2026-06-11

  Afatinib’s irreversible ErbB kinase inhibition empowers advanced assembloid models to reveal true tumor–stroma interactions and resistance mechanisms. Discover how to optimize protocols, interpret complex drug responses, and troubleshoot key technical hurdles using APExBIO’s high-purity Afatinib in translational cancer biology research.

• Afatinib (BIBW 2992): Precision EGFR Pathway Inhibition in A

  2026-06-11

  Afatinib’s irreversible ErbB kinase inhibition empowers advanced assembloid models to reveal true tumor–stroma interactions and resistance mechanisms. Discover how to optimize protocols, interpret complex drug responses, and troubleshoot key technical hurdles using APExBIO’s high-purity Afatinib in translational cancer biology research.

• nor-NOHA Acetate: Optimizing Arginase Inhibition in Cancer M

  2026-06-11

  nor-NOHA (acetate) enables precise modulation of arginine metabolism, unlocking advanced research workflows in cancer and endothelial biology. Learn how to apply, troubleshoot, and leverage this potent arginase inhibitor for reproducible, high-impact results in your experimental systems.

15675 records 1/1045 page Next 12345 下5页 Last page